"Refractory GERD": Acid, nonacid, or not GERD?

American Journal of Gastroenterology

Volumn 99, Issue 6, 2004, Pages 989-990

  Vaezi, Michael F ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ANEMIA; BILE REFLUX; BILITEC MONITORING; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DYSPHAGIA; ESOPHAGOGASTRODUODENOSCOPY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; HEARTBURN; HUMAN; IMPEDANCE; MAINTENANCE THERAPY; PATIENT MONITORING; PH MEASUREMENT; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; REVIEW; RISK FACTOR; SINGLE DRUG DOSE; SPECTROPHOTOMETRY; STOMACH FUNDOPLICATION; STOMACH PH; UNITED STATES; WEIGHT REDUCTION;

DIAGNOSIS, DIFFERENTIAL; DUODENOGASTRIC REFLUX; FEMALE; GASTRIC ACID; GASTROESOPHAGEAL REFLUX; HISTAMINE H2 ANTAGONISTS; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; PROGNOSIS; PROTON PUMPS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT FAILURE;

EID: 3142730876     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.04166.x     Document Type: Review

References (11)

1. Locke GR III, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: A population based study in Olmstead County, Minnesota. Gastroenterology 1997;112:1448-56.
2. A Gallup Organization National Survey. Heartburn across America. Princeton, NJ: Gallup Organization, 1998.
3. Chiba N, De Gara CJ, Wilkinson JM, et al. Speed of healing and symptom relief in grade 11 to IV gastroesophageal reflux disease: A meta analysis. Gastroenterology 1997;112:1798-810.
4. Tack J, Koek G, Demedts I, et al. Gastroesophageal reflux disease poorly responsive to single dose proton pump inhibitors: Acid reflux, bile reflux or both? Am J Gastroenterol 2004. doi: 10.1111/j.1572-0241.2004.04171.x.
5. Vaezi MF, LaCamera RG, Richter JE. Bilitec 2000 ambulatory duodenogastric reflux monitoring system. Studies on its validation and limitations. Am J Physiol 1994;267:G1050-G1057.
6. Vaezi MF, Richter JE. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology 1996;111:1192-9.
7. Srinivasan R, Vela MF, Katz PO, et al. Esophageal function testing using multichannel intraluminal impedance. Am J Physiol 2001;280:G457-G462.
8. Sifrim D, Holloway R, Silny J, et al. Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH impedance recordings. Gastroenterology 2001;120:1588-98.
9. Vela MF, Camacho-Lobot L, Srinivasan R, et al. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: Effect of omeprazole. Gastroenterology 2001;120:1599-606.
10. Shay S, Sifrim D, Tutuian R, et al. Multichannel intraluminal impedance in the evaluation of patients with persistent GERD symptoms despite proton pump inhibitors (PPI): A multicenter study. Gastroenterology 2003;124:A537.
11. Pandolfino JE, Richter JE, Ours T, et al. Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol 2003;98:740-9.